Reports; Information a. You acknowledge and agree that:
(i) The Fund and/or the Manager may provide you and other Interestholders with information relating to the Fund in addition to information that is required to be delivered by the Prospectus and Statement of Additional Information or applicable law (“Additional Information”);
(ii) Additional Information is provided by the Fund and/or the Manager in its sole discretion, and the Fund and/or the Manager may cease to provide such information relating to the Fund at any time without prior notice;
(iii) Although the Fund and/or the Manager shall act in good faith in preparing Additional Information (which preparation will be limited as described herein), any Additional Information that is provided to you (a) may be based on estimated data (including, if applicable, estimated data provided by any underlying funds in which the Fund invests) that will not reflect reconciliation with records of the Fund’s (or any underlying fund’s) custodian and/or administrator, as applicable, and (b) may not reflect the accrual of certain expenses and liabilities of the Fund (or any underlying fund in which the Fund invests, if applicable), including, without limitation, fees and performance-based compensation payable by the Fund. Accordingly, any valuations or returns provided in any Additional Information may be preliminary, estimated and unaudited, and will be subject to high levels of uncertainty. Actual returns may vary significantly from such estimated returns and should not be construed as providing any assurance or guarantee as to actual returns;
(iv) Neither the Fund nor the Manager makes any representation as to the accuracy, completeness, fitness for a particular purpose or timeliness of any Additional Information that is provided to you, and you accept liability for any loss you suffer as a result of reliance upon any such Additional Information; and
(v) Interests will only be issued, and redemptions will only be made, on the basis of the Fund’s official NAV and subject to the terms and conditions set forth in the Prospectus and Statement of Additional Information and not on the basis of information set forth in any other Additional Information.
b. To the extent that any report or information relating to the Fund received by you contains details of any investment positions, trading strategies or techniques of the Fund or the investment processes of the Manager, you shall not use such information as a basis for effecting or replicating ...
Reports; Information. 8.1. You will be provided with contract notes for each Investee Company transaction by Xxxxxx.
8.2. Xxxxxx shall send you a report relating to the Fund, complying with the FCA rules, every six months, in respect of the periods ending on or around April and October. The Fund will be valued by Xxxxxx based on Investee Company valuations carried out by Xxxxxx in accordance with IPEVC Valuation Guidelines from time to time prevailing.
8.3. Xxxxxx shall supply such further information which is in its respective possession or under its control as you may reasonably request as soon as reasonably practicable after receipt of such request.
8.4. Any contract notes, statements, reports or information so provided by Xxxxxx or the Nominee to you will state the basis of any valuations of Investments provided.
Reports; Information a. You acknowledge and agree that:
(i) The Fund and/or the Manager may provide you and other Members with information relating to the Fund in addition to information that is required to be delivered by the Fund Agreement, the Memorandum or applicable law, including, without limitation, Performance Reports (“Additional Information”);
(ii) Additional Information is provided by the Fund and/or the Manager in its sole discretion, and the Fund and/or the Manager may cease to provide such information relating to the Fund at any time without prior notice;
Reports; Information. That the Contractor agrees to provide the FA with timely reports and information as requested which includes participant monthly invoice payment requests. Additionally, Contractor agrees to provide the Title I Operator with monthly participant progress reports.
Reports; Information. 115 Section 6.9
Reports; Information a. You acknowledge and agree that:
(i) The Company and/or the Manager may provide you and other Shareholders with information relating to the Company in addition to information that is required to be delivered by the Memorandum or applicable law (“Additional Information”);
(ii) Additional Information is provided by the Company and/or the Manager in its sole discretion, and the Company and/or the Manager may cease to provide such information relating to the Company at any time without prior notice;
Reports; Information. If requested by the Planning & Development Services Director, Permittee shall provide any such documentation/report as necessary to ascertain compliance with the Conditional Use Permit. The format, content and supporting documentation shall be as required by the Planning & Development Services Director.
Reports; Information. Hymedix shall submit to ProCyte a written report no less frequently than every six (6) months which covers the then current technical status, the results achieved, the improvements and inventions made, the problems being encountered and other pertinent information relating to the Program. Hymedix shall keep, and shall cause its consultants to keep, complete, accurate and authentic accounts, notes, data and records of the research and development performed under the Program in accordance with established laboratory practices and in accordance with the directions of ProCyte for purposes of patent protection, publication, etc. At the request of ProCyte, upon reasonable notice and during reasonable business hours, ProCyte may inspect and make copies of such accounts, notes, data and records subject to Section 9. ProCyte may require that certain aspects of the Program and resulting Licensed Technology be kept confidential and not be disclosed to others, except in accordance with applicable patent laws. Any inventions, discoveries, improvements, results and data of Hymedix (including its consultants) from the Program shall become Licensed Technology under this Agreement. From time to time ProCyte may discuss and provide information (e.g., market information) to Hymedix in connection with the Program, which information shall be subject to Section 9.
Reports; Information. Reports and analysis furnished by NSL in connection with services performed shall become the property of the Customer upon full payment. Notwithstanding the foregoing, no such report or analysis may be reproduced, in whole or in part, or communicated to, or relied upon, by any third party, without the prior consent of NSL. Moreover, in the absence of such consent, the Customer shall not specifically refer to NSL or its furnishing of any such analysis or report in any promotional literature or advertising.
Reports; Information. To the extent that any report or information relating to the Fund received by you contains details of any investment positions, trading strategies or techniques of the Fund or the investment processes of the Manager, you shall not, and shall cause each person to whom you have disclosed information relating to the Fund pursuant to paragraph 10 not to, use such information as a basis for effecting or replicating any transactions, or for any purpose other than for your analysis of the performance of the Manager and/or the Fund, of the Fund’s compatibility with other investments you may hold, or for any other similar purpose for which you have specifically requested, and obtained, the written agreement of the Manager. Without limiting the foregoing, you represent and warrant that you have proper protocols in place, or will adopt such protocols, to ensure that information relating to the Fund will be protected against dissemination to other entities, or other groups, divisions and/or persons within your organization, including, but not limited to, persons that are involved in portfolio management decisions or any other entity, group, division and/or person within your organization that may use information relating to the Fund in a manner other than for purposes of managing the investment in the Fund. You agree that no person who has access to information relating to the Fund can use such information for trading purposes. For the avoidance of doubt, for Subscribers that are fund-of-funds, portfolio management divisions do not include the fund-of-funds division managing the investment in the Fund.
